Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts fear that Health and Human Services Secretary Robert F. Kennedy, Jr.’s, recent funding cuts will have “a profound chilling effect” on U.S. progress in this area of medicine.
The new mRNA vaccines are specifically engineered to address the genetic differences of each patient with stomach cancer, according to Japanese researchers in a study published Tuesday, which makes them more effective than standard treatments.